2 directorsName hiddenVisible after signing in and 1 other
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Gross margin from €248,230 to €213,144Result from €10,537 to €30,584Staff from 1.5 FTE to 1.3 FTEEquity from €119,798 to €150,381Debts from €341,717 to €426,501
A director left. Latest change 21-08-2026 · 1 in office.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 6,715 companies had the same profile as I&L Biosystems Belgium has now. Each dot stands for 17 companies, two years later.
95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
Micro
5 to 10 years old
solvency 10 to 30%
a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,715 companies, not a prediction for I&L Biosystems Belgium. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Name after signing inVisible after signing in resigns as director
General meeting of 03-09-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0758457450
2 directors appointed, 2 resignationsName hiddenVisible after signing in and Hidden nameVisible after signing in resign · Name after signing inVisible after signing in and Name hiddenVisible after signing in appointed · Director discharge: Hidden nameVisible after signing in · General meeting of 19-07-2024 · Gazette deed
Incorporation
Founding capital of €25,000, 100 shares · Founded by Name after signing inVisible after signing in · Name hiddenVisible after signing in (director) and Hidden nameVisible after signing in (director) appointed · published on 18-11-2020 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as I&L Biosystems Belgium: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €287,000 and €744,000, founded between 2018 and 2022.
What is the company number of I&L Biosystems Belgium?
The company number of I&L Biosystems Belgium is 0758.457.450. The VAT number is the same number with BE in front: BE 0758.457.450.
Where is I&L Biosystems Belgium based?
The registered office is at Martelarenplein 20, 3000 Leuven.Company details
What does I&L Biosystems Belgium do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of I&L Biosystems Belgium?
I&L Biosystems Belgium is a private limited company (BV).
When was I&L Biosystems Belgium founded?
I&L Biosystems Belgium was founded on 16-11-2020.
Is I&L Biosystems Belgium still active?
Yes, I&L Biosystems Belgium is an active enterprise in the KBO register.
How many employees does I&L Biosystems Belgium have?
I&L Biosystems Belgium had an average of 1.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does I&L Biosystems Belgium fall under?
In its 2024 annual accounts, I&L Biosystems Belgium states joint committees 116 (Chemical industry) and 207 (White-collar workers in the chemical industry).
What is the turnover of I&L Biosystems Belgium?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €213,144 and 86 comparable companies (NACE 46). It probably lies between €510,000 and €2.0m.
Is I&L Biosystems Belgium profitable?
In financial year 2025, I&L Biosystems Belgium made a profit of €30,584.
Where can I find the annual accounts of I&L Biosystems Belgium?
I&L Biosystems Belgium filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of I&L Biosystems Belgium due?
I&L Biosystems Belgium must file the annual accounts for financial year 2026 by 31-07-2027.Timeline